Using covalent dimers of human carbonic anhydrase II to model bivalency in immunoglobulins.
about
Structural and biophysical characterization of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2: insights into engineering thermostable enzymes for CO2 sequestrationMultivalent recognition of histone tails by the PHD fingers of CHD5Dextran as a generally applicable multivalent scaffold for improving immunoglobulin-binding affinities of peptide and peptidomimetic ligands.Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive Measurements.Highly efficient binding of paramagnetic beads bioconjugated with 100,000 or more antibodies to protein-coated surfaces.Multivalency as a chemical organization and action principle.Assessing cooperativity in supramolecular systems.Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system.Selective precipitation and purification of monovalent proteins using oligovalent ligands and ammonium sulfate.Interferon dimers: IFN-PEG-IFN.The Delicate Balance of Preorganisation and Adaptability in Multiply Bonded Host-Guest Complexes.Quantifying the rebinding effect in multivalent chemical ligand-receptor systems.A Divalent Pentastable Redox-Switchable Donor-Acceptor Rotaxane.Allosteric and Chelate Cooperativity in Divalent Crown Ether/Ammonium Complexes with Strong Binding Enhancement.Reversible blocking of antibodies using bivalent peptide–DNA conjugates allows protease-activatable targeting
P2860
Q28635308-F6F984AF-D9C8-4670-A937-6FA9A7BBB7A6Q34352597-59E97BDA-FF52-4EC5-8712-0407F5812CE5Q34431415-C76592F2-14A0-47A7-9B36-033CF461A075Q35901341-41789CF5-DEE3-4E50-A248-A7390A839BE5Q36445836-2E07A135-F804-4F65-9F3F-1645779A6279Q38041060-7C592286-8261-41D0-B0C9-0B17254FF25AQ38869855-55984713-7DDE-45E7-8CA9-43EE577FBCD6Q40862828-6C4C235E-64DC-48E1-806D-5B65DE4AE742Q41858511-F66E1331-201E-4A22-AFEF-4C9822A05D7DQ47939716-324269A0-650B-4092-9E34-440F48AD62B4Q48176912-2F854620-7B9A-4127-AF07-A3F899C24D1DQ50942741-E2E13547-172F-4F20-84D7-83699502E386Q52842778-665CC1DF-FE89-454B-A052-BF6F5172C16EQ52847794-07A8CA79-AF4C-4E87-823A-79BAFBFA6353Q58002507-036D001F-DCAE-4DA1-8D1D-39B7B8E633B8
P2860
Using covalent dimers of human carbonic anhydrase II to model bivalency in immunoglobulins.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Using covalent dimers of human ...... bivalency in immunoglobulins.
@en
Using covalent dimers of human ...... bivalency in immunoglobulins.
@nl
type
label
Using covalent dimers of human ...... bivalency in immunoglobulins.
@en
Using covalent dimers of human ...... bivalency in immunoglobulins.
@nl
prefLabel
Using covalent dimers of human ...... bivalency in immunoglobulins.
@en
Using covalent dimers of human ...... bivalency in immunoglobulins.
@nl
P2093
P2860
P356
P1476
Using covalent dimers of human ...... bivalency in immunoglobulins.
@en
P2093
Eric T Mack
George M Whitesides
Phillip W Snyder
Raquel Perez-Castillejos
P2860
P304
11701-11715
P356
10.1021/JA2038084
P407
P577
2011-07-07T00:00:00Z